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Abstract 
Background: In view of the urgency of results quality and operational availability of point of care 
analyzers is of high importance in ICUs and operational theatres.  
Methods: We investigated the influence of time on release and total amount of Heparin in various 
types of syringes used for blood gas analysis (BGA). Heparin activity in three types of liquids 
(electrolyte solution, fresh frozen plasma and whole blood) was quantified in its time dependency. 
The ability of clot formation was measured with rotation thrombelastography in whole blood. All 
tests were done with three types of preanalytical procedures (“resting”, “rolling” and “rotating”). 
Results: We found different time dependencies of heparin activities in syringes releasing dried 
heparin from pads, the inner syringe wall or liquid heparin solutions during the first 20 minutes 
after liquid aspiration. The heparin activities lie in a wide range below or above their nominal 
content in 200µl aliquots withdrawn from the BGA-samples. Preananlytical treatment has influence 
particularly on the range of heparin activity during the first 10 minutes.  
Conclusion: The risk of blockages by clots in analyzers is lower when syringes with liquid heparin 
or heparin dried at the inner syringe wall are used. 
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Introduction 
During the last decades many efforts have been done to upgrade reliability, speed, accuracy and 
operational availability of blood gas analyzers [1]. Oximetry and sensor stability allow extremely 
long durability in analyzers up to several years. The sensors with the shortest lifetime are biosensors 
with immobilized enzyme systems for the identification and quantification of glucose and lactate. It 
is obvious that quality of the measurement is strongly dependent on the quality of the sample matrix 
[2] and its homogeneity [3]. Sensor membranes, valves and gaskets are not built to e.g. resist 
stomach acid and there is no permission for testing e.g. intraperitoneal liquids to estimate pH or 
hemoglobin in it. It is also obvious, not to aspire unheparinized blood samples routinely into a 
blood gas analyzer, because clotting and blockage is the inevitable consequence. Every disturbance 
of the operational availability of point of care analyzers is associated with higher costs and a 
missing basis for urgent therapeutic interventions. 
Manufacturers of syringes for blood gas analysis sell their products loaded with a wide range of 
heparin activities. The way of application heparin into blood by the syringes is also variable (both 
shown for the syringes used in our study in table 1). All of these products should safely avoid 
coagulation in the syringe and in consequence in blood gas analyzers. The general order for 
preanalytical handling samples is to rotate them without air bubbles and to transfer blood as soon as 
possible into an analyzer. None of the users would expect that measurement of a syringe resting at 
room temperature for 20 min or more would lead to reliable, unattended results [4, 5]. In clinical 
routine most of the samples reach the analyzer within 5 minutes as speed in return of results is 
general purpose of any point of care system. 
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Information which level of heparin activity in syringes is sufficient for ongoing anticoagulation in 
artificial vessels as BGA syringes and the analyzers themselves is given by WHO or IFCC (ISO 
DIS 6710) [6]. We quantified anticoagulation activity in blood (or other liquid) samples drawn with 
different systems handled on different levels of clinical practice to fix the current, time 
corresponding potency of anticoagulation.  
Depending on the number of parameters modern analyzers only consume about 35 µl up to 200 µl 
blood volume. Total syringe volumes between 1 and 3.5 ml always imply the risk of 
inhomogeneous release of heparin and therefore an insufficient heparinized aliquot of blood might 
be aspired. 
Materials and Methods 
Determination of Heparin activity:  
Berichrom Heparin test (Dade Behring Marburg GmbH, Marburg, Germany) was modified to fit 
96-well-plates despite the provided 1 cm cuvettes. Total perfusate/FFP/blood volume needed for 
each test could be reduced to 10 µl. Standard curves were prepared with Heparin-Natrium-25.000-
ratiopharm (Ratiopharm GmbH, Ulm, Germany) on every 96-well-plate and every test liquid. 
Clot formation: 
To identify potency of clot formation in analyzers we measured blood samples with rotation 
thrombelastography (ROTEM, Pentapharm, Munic, Germany. Three tests are performed: InTEM, 
ExTEM with every blood sample and HepTEM additionally with the last sample of every series.  
The funding corporate sponsor Sarstedt AG&Co had no influence on any tasks of the manuscript. 
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Quality control 
Heparin activity test: 
Every 96-well-plate was loaded in the same manner. The first 20 wells were used for calibration 
(Blank and 0.1 i.U./ml to 1 i.U./ml). Depending on the investigated matrix calibrators were 
prepared in Perfusate or FFP. The next wells were 4 spiked samples (Perfusate (pH 7.4; Na+ 149 
mmol/l; K+ 5.5 mmol/l; Mg++ 0.5 mmol/l; Ca++ 1.15 mmol/l, Cl- 130 mmol/l, HCO3- 25 mmol/l; 
PO4--- 2.8 mmol/l, Glucose 5.5 mmol/l ) or FFP) on two different activity levels (twice 0.17 i.U./ml 
and 0.75 i.U./ml) followed by two commercially available probes (Dade Ci-Trol Heparin Control 
Low, Dade Behring). The last 6 well were spiked just the same. In between all unknowns were 
quantified after adequate dilution with Perfusate or FFP (Dilution factors between 10 and 100) not 
to extend the calibration curve. Whole blood samples were also diluted with FFP.  
Rotem: 
Rotrol N (Pentapharm, Munich, Germany) normal control for thrombelastometry was used to verify 
the functionality of the Rotem on every working day.  
Setup part 1: Testing of heparin activity in 8 syringe types with non – 
blood liquids. 
We simulated the preanalytical situation in clinics defining three attending types and quantified the 
heparin activity at 0.25; 0.5; 0.45; 1; 2; 3; 4; 5; 10; 15 and 20 min after contact between the test 
liquids and heparin. 
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“Resting”: Worst case situation: Sample liquid is aspired into a heparinized syringe, shaken once, 
rested on the table until it is taken again, once shaken and 200µl volume are sucked with a needle 
into a plastic syringe out of the middle of the sample. 
 “Rolling”: Normal case situation: Sample liquid is aspired into a heparinized syringe and rolled by 
hand until removal of 200µl volume. 
“Rotating”: Superior case situation: After aspiration the heparinized syringe is rotated mechanical 
with 10 turns per minute along its long axis of rotation. 
We used two different test liquids (perfusate∗ and pooled FFP) to overcome variability in e.g. 
protein content and two lot numbers (table 1) per syringe type. Every syringe was tested in two 
series per lot. Every heparin test was done in duplicate. 
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104 Table 1 Tested Blood Gas Samplers. Types of heparin formylation and activity per ml 
Purchaser/ 
Lot Numbers 
Syringe type / 
nominal volume 
Formylation Heparin Amount [i.U./ml] / 
characterization 
Beckton Dickinson 
7046333 / 7073875 
A-Line / 3 ml Liquid 27 / Ca balanced Lithium 
Heparin 
Radiometer 
RY05 2008-09 / TA 03 
2008-11 
PICO 50 / 2 ml Dry on a 
mobile pad 
40 / electrolyte balanced 
Heparin 
Westmed, Tucson, AZ  
34710 / 34988 
PULSSET / 3 ml Dry 8.3 / 
Balanced Heparin 
Radiometer 
TJ-01 2009-01 / TR-01 
2009-04 
PICO 70 / 1.5 ml Dry on a 
mobile pad 
40 /  
compensated Heparin 
Sarstedt 
7091002 / 7092202 
BG-Monovette /2 ml Liquid 50 / Ca balanced Lithium 
Heparin 
Smith-Medical 
1085040 / 1129201 
Pro-Vent / 3 ml Dry  23 / dried Lithium Heparin 
Bayer 
1051566 / 1116183 
Rapidlite / 3ml Spray dried 
at the inner 
wall 
23 / Ca balanced Lithium 
Heparin 
Roche 
702001 / 708002 
BS2 / 2 ml Liquid 15 / Sodium-Heparin 
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Setup part 2: Testing of heparin activity and clot firmness in 2 types of 
syringes with whole blood. 
Citric blood from 18 healthy volunteers was taken with written consent by the local ethics 
committee and heparin activity tested under the same conditions as mentioned above. 1 ml blood 
was aspired out of the BGA syringes at the specified time points. The higher blood volume was 
needed to process thrombelastometric measurements. The syringe with the highest liquid heparin 
content and one with heparin on a pad were chosen because in these two syringe types the biggest 
distinctions are to be expected from the results of part one investigations. With this attempt not only 
variations in heparin activity could be identified, but also a magnitude of real clot formation in 
Analyzers could be quantified. 
Statistics: 
To create a meaningful parameter for comparison of each syringe type heparin activities of the 
beginning 10 min a Simple E-max model (Software WinNonLin, Pharsight Corporation, Mountain 
View, CA) was used to calculate a fitting curve. The areas under these curves were compared with 
SPSS 15.0.01 for Windows (SPSSinc, Chicago, Illinois).  
Results 
Details of quality control results for the determination of heparin activity are given in table 2. 
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122 Table 2: Results of quality controls for heparin activity. 
Target value 
[i.U./ml] 
Mean 
[i.U./ml] 
N Bias 
[%] 
SD 
[i.U./ml] 
Number of 
plates 
Inter – plate SD 
[i.U./ml] 
0.17 0.148 292 -13 0.0421 66 0.0288 
0.75 0.722 268 -3.8 0.0919 66 0.0638 
Ci-Trol-low 0.274 264 - 0.0936 66 0.0892 
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To compare the results of maximum heparin activity identified by the BeriChrom-test with the 
activity given from the purchaser we averaged the activity in the tests at 10, 15 and 20 min after 
application of the liquids into the blood-gas-syringes. This implies the assumption that a contact 
time of 10 min is nearly sufficient for the total release of heparin into the test solutions. This can be 
proven e.g. by a plot of mean relative heparin activities in FFP. (figure 1)  
Figure 1: Time dependency of relative heparin activities in BGA-syringes measured in FFP. The 
three types of clinical preanalytical treatment are averaged. Each data point results from 36 
analyzed syringes. 
 132 
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Absolute heparin activity data have to be accepted under reserve, because we calibrated the 
BeriChrom test with one type of heparin. Results are given in table 3 wherein the high bias for 
measured maximum mean values is probably due to the single type calibration. 
Table 3 Relative Areas under the curve of heparin activities released during the first 10 minutes after aspiration.  
Formylation AUC[%] [%] Number Post Hoc Bonferroni significance niveau p
 Mean SD N liquid Pad Dry 
Liquid 89.3 21.8 72  0.00001 0.48 
Pad 66.3 24.9 48 0.00001  0.001 
Dry 83.4 28.3 72 0.48 0.001  
 137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
Despite the lack of missing calibration material for all syringe types we found the nominal heparin 
activity quite precisely in three of the syringe types (Monovette, Rapidlite and A-Line) in Perfusate 
(Bias less than ±5%).  
Deviations between -66% and +80% were found in the other syringes (table 3) 
As marker for differences in heparin release during the observed time period we chose the relative 
AUC (WinNonLin, Pharsight, Mountain View, CA) calculated from 0 to 10 minutes versus heparin 
activity standardized to averaged values from 10, 15 and 20 minutes after aspiration. The 
standardization was done separately for every liquid, modus and syringe type. We found strong 
significant differences in relative AUCs between the liquid and the other two types of heparin 
formulation. (table 4) Gaussian distribution was tested with a q-q Plot and p values were calculated 
with one way anova and Bonferroni Post Hoc analysis.  
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Table 4: Mean heparin activities in the BGA-syringes 10 to 20 min after aspiration. Each mean value is 
quantified with the same type of calibrator (heparin-sodium; ratiopharm). The denoted bias is in relation to the 
desired values given by the purchaser. 
Activity Pro 
Vent 
Mono-
vette 
PICO 
50 
Rapid-
lyte 
A-
Line 
PICO 
70 
BS2 Puls-
set 
mean
Mean perfusat i.U./ml 27.0 49.0 28.9 24.0 26.9 32.7 6.5 15.0   
SD perfusat 11.1 7.1 8.9 9.9 8.6 10.2 1.9 3.6   
Bias perfusat % 17.5 -2.0 -27.8 4.5 -0.2 -18.4 -56.6 79.8 -0.4 
mean FFP i.U./ml 21.5 43.9 23.0 16.3 21.7 25.0 5.0 13.9   
SD FFP 9.6 7.2 10.3 9.9 9.1 10.0 1.1 4.6   
Bias FFP % -6.4 -12.2 -42.5 -29.2 -19.7 -37.6 -66.4 66.4 -18.4 
Desired value 
i.U./ml 
 
23.0 
 
50.0 
 
40.0 
 
23.0 
 
27.0 
 
40.0 
 
15.0 
 
8.3 
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By employing a pharmacodynamic Simple Emax – model on the normalized heparin activities a 
table of time points corresponding to the release of 8 i.U./ml Heparin (minimum required amount) 
was calculated (figure 2).  
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Figure 2: Calculated time [min] to release about 8 i.U./ml heparin activity in BGA syringes in 
perfusate, FFP or in blood (two syringes only) under different preanalytical conditions. 
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Using the curves and defining the last calculated value as 100% time points could be identified until 
defined values of relative heparin activities are to be expected.  
With liquid heparin from Monovettes in 10% of the syringes with the resting preanalytic treatment a 
clot firmness of more than 50 % could be detected (table 5). With PICO 50 between 30 and 100% 
of all syringes had a MCF of more than 50%. Time dependency of all mean INTEM – MCF results 
are shown in figure 3. 
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Figure 3: Results from ROTEM measurements of maximum clot formation [MCF] along the 
intrinsic pathway (mean of nine measurements per point). 
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A direct linear correlation between MCF and relative heparin activities could be found (EXTEM: 
r^2 = 0.91 and INTEM: r^2 = 0.66 for PICO 50 syringes; EXTEM: r^2 = 0.32 and INTEM: no 
correlation, because MCF was always below 5 mm for Monovettes 
Discussion 
The sum of data we obtained from quantifying heparin activities in Perfusate and fresh frozen 
plasma indicates that liquid formulation of heparin in BGA syringes leads to the fastest heparin 
detachment in solutions. Other formulations release their stock of heparin slower. We tried to 
answer the question whether even smaller amounts of heparin, released within the first few minutes 
lead to a sufficient heparinization by combining the quantification of heparin activity with the 
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determination of maximum clot firmness out of identical samples of whole blood. (figure 4 and 
table 5).  
Figure 4: Relative AUCs during the first 10 min after aspiration of whole blood in two different 
syringes depending on the preanalytic modus. Data are corrected by the calibration bias in perfusat. 
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Table 5: Portions of Syringes (PICO 50 and Monovette) producing no reduction in clot firmness (MCF more 
than 50 mm) and 50% or less reduction (MCF more than 25mm) independently of contact time within 20 
minutes.  
Treatment MCF more than 50 mm MCF more than 25 mm 
 in-TEM % ex-TEM % in-TEM % ex-TEM % 
 PICO Monovette PICO Monovette PICO Monovette PICO Monovette
Rolling 10 0 30 0 20 0 50 0 
Resting 30 0 90 0 70 0 100 10 
Rotating 0 0 40 0 30 0 90 0 
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The high significant differences in relative AUC (0-10min) correspond to the higher portions of 
syringes with no or insufficient reduction in clot firmness (MCF = normal or more than 25 mm).  
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The considered amount of required heparin activity varied during the last 25 years from 20 i.U./ml 
[7] to 4-6 i.U./ml [8] for plastic syringes. WHO guidelines from 2002 assume distinctive levels of 
unfractionated heparin (lithium, sodium or ammonium heparin from 12 to 30 i.U./ml) to get 
standardized heparinized plasma. Dry calcium titrated heparin from 40 to 60 i.U./ml and in liquid 
formulation 8 to 12 i.U./ml should be used to determine ionized calcium. 
Assuming that the heparin release in syringes is completed after 20 min and that the calculated 
Simple E-Max model reflects the specified heparin activities we calculated the necessary time 
period to achieve the contemplated 8 i.U./ml. (figure 2) 
To existing discussions about syringe types [9-12], preanalytical errors [4, 13] or influences of 
Heparin formulation on quantitation results [8, 14-23] e.g. due to dilution [24, 25], changes in time 
depending contents [11, 26-28], carryover [29], heparin amounts (less than 15 iU/ml lithium or 
sodium heparinate and less than 50 iU/ml calcium heparinate) [18, 30, 31] or necessity of heparin in 
single use cuvettes [32] we have to ad a time resolved clotting discussion.  
With this investigation we could proof the qualitative different heparin release namely liquid > dry 
at the syringe inner wall > dry on pads in BGA syringes. We also showed that preanalytical 
treatment rolling (by hand) is superior to rotating (mechanical 10/min) and resting.  
Resting however (shaking once at aspiration of blood and once again before removal of the 200 µl 
aliquot) is responsible for a prolongation of release particularly with regard to the heparin 
containing pads. The ROTEM analysis showed that the heparin activity correlates with clot 
firmness. In worst case situation no reduction in clot firmness activated along the extrinstic pathway 
was found over 15 min (data not shown) in resting syringes with heparin on pads. The usual clinical 
preanalytical treatment can be assumed as somewhere in between rolling and resting. Therefore a 
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perfect anticoagulation from the first moment of aspiration is not achievable for any syringe type. 
Anyhow the use of liquid heparin formulation is superior to spray dried and in particular to dried 
heparin on pads.  
Relative AUCs of heparin activity from beginning of aspiration to 10 minutes fit to ROTEM results. 
The relative AUC (0-10min) lies for PICCO 50 syringes between 3 and 49 % and for the 
Monovettes between 55 and 101% of the maximum possible theoretical value (when heparin 
activity results are corrected with the factor found in Perfusate calibrations) (figure 4). With these 
results we could classify the firmness of clot formation in different types of BGA syringes.  
To demonstrate the real effect on the functionality of a blood gas analyzer three pictures of the 
waste outlets of a Siemens (former Bayer Diagnostics) 1265 blood gas analyzer are shown (figure 5 
a-c). The instrument was in use for about one week (about 400 measurements) in our neurosurgical 
– anesthesiological ICU with every of the three syringe types. a) Bayer Rapidlite b) Radiometer 
PICO 50 and c) Sarstedt Monovette 
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Figure 5a-c: Photographies of waste outlets of a Siemens 1265 BGA after charging with about 400 
blood samples for each syringe type a) Rapidlyte b) PICO 50 and c) Monovette 
a) Rapidlyte 
 232 
233 b) PICO 50 
 234 
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235 c) Monovette 
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Blood Gas Analysis = BGA, Rotationthrombelastometry = ROTEM, Fresh Frozen Plasma = FFP, 
Area under the Curve = AUC; Maximum Clot Firmness = MCF 
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